Nov 08, 2023 / 01:00PM GMT
Operator
Good day, and welcome to the Lexicon Pharmaceuticals Third Quarter 2023 Financial Results Conference Call. (Operator Instructions) Please note that today's event is being recorded.
I would now like to turn the conference over to Carrie Siragusa. Please go ahead.
Carrie Siragusa - Lexicon Pharmaceuticals, Inc. - Former Executive Director of Corporate Strategy & IR
Thank you, Craig. Good morning, and welcome to the Lexicon Pharmaceuticals Third Quarter 2023 Financial Results Conference Call. Joining me today are Lonnel Coats, Lexicon's Chief Executive Officer; Jeff Wade, Lexicon's President and Chief Financial Officer; Dr. Craig Granowitz, Lexicon's Senior Vice President and Chief Medical Officer; and Tom Garner, Lexicon's Senior Vice President and Chief Commercial Officer.
Earlier this morning, Lexicon issued a press release announcing our financial results for the third quarter of 2023, which is available on our website at www.lexpharma.com and through our SEC filings. A
Q3 2023 Lexicon Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot